Mozart Therapeutics
Mozart Therapeutics develops therapies for celiac disease and other immune-related conditions.
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology, Biopharma, Immunology
- Founded
- 2023
- Type
- Corporation Seattle business license
- Registered name
- Mozart Therapeutics Inc Seattle business license
- Stage
- Series C
Is this your organization? Claim it
Ally.io raises $50M Series C, bringing total funding to $76M; investors include Accel, Addition, GreenOaks
Ally.io, a Seattle-based company led by co-founder & CEO Vetri Vellore, has raised $76M total with a $50M Series C as its most recent round in February 2021, backed by investors including Accel, Addition, and GreenOaks.
Mozart Therapeutics Raises $25M to Advance Autoimmune Disease Drug MTX-101 with FDA IND Planned for Early 2024
Seattle biotech Mozart Therapeutics secured $25 million to advance MTX-101, its drug candidate for autoimmune gastrointestinal diseases, aiming for FDA IND submission by early 2024. The company, led by CEO Katie Fanning and supported by notable investors, has raised a total of $80 million since its 2020 launch.
Juno Therapeutics’ 2013 launch spurred Seattle cell-therapy boom after $300M+ raise and $9B+ 2018 sale to Celgene
Juno Therapeutics, founded in 2013, accelerated cell therapy development by raising over $300 million, going public within a year, and selling to Celgene for more than $9 billion in 2018, and its alumni spawned many Seattle-area biotech startups. The company’s success attracted capital, validated Seattle as a cellular and gene therapy hub, and influenced the region’s biotech entrepreneurship and leadership.
See all 7 stories, episodes and videos about Mozart Therapeutics.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Katie Fanning Executive, President and Chief Executive Officer